Trial Site Detail

 

Drug:
Belzutifan
Trial:
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Instituto Europeo di Oncologia

     
Milano ,
Italy

 

Principal Investigator:
Contact:
Study Coordinator +390257489258
Activation Status of this Site:
Active
Notes about this Site:
Instituto Europeo di Oncologia Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.